JP2007513095A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007513095A5 JP2007513095A5 JP2006541759A JP2006541759A JP2007513095A5 JP 2007513095 A5 JP2007513095 A5 JP 2007513095A5 JP 2006541759 A JP2006541759 A JP 2006541759A JP 2006541759 A JP2006541759 A JP 2006541759A JP 2007513095 A5 JP2007513095 A5 JP 2007513095A5
- Authority
- JP
- Japan
- Prior art keywords
- pipamperon
- compound
- selective serotonin
- reuptake inhibitor
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/725,965 US7884096B2 (en) | 2003-12-02 | 2003-12-02 | Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
| EP03447279A EP1547650A1 (en) | 2003-12-02 | 2003-12-02 | Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
| CA2451798A CA2451798C (en) | 2003-12-02 | 2003-12-02 | Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists |
| EP04447001 | 2004-01-05 | ||
| US10/752,423 US7855195B2 (en) | 2003-12-02 | 2004-01-06 | Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
| EP04447066A EP1576985A1 (en) | 2004-03-18 | 2004-03-18 | Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
| US10/803,793 US20050119249A1 (en) | 2003-12-02 | 2004-03-18 | Method of treating neurodegenerative diseases using D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
| CA 2461248 CA2461248C (en) | 2003-12-02 | 2004-03-18 | Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists |
| EP04025035A EP1541197B8 (en) | 2003-12-02 | 2004-10-21 | Use of pipamperone and an SNDRI, SNRI or SSRI for the treatment of mood or anxiety disorders |
| US10/984,683 US20050203130A1 (en) | 2003-12-02 | 2004-11-09 | Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
| PCT/BE2004/000172 WO2005053796A1 (en) | 2003-12-02 | 2004-12-02 | Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007513095A JP2007513095A (ja) | 2007-05-24 |
| JP2007513095A5 true JP2007513095A5 (https=) | 2007-12-27 |
| JP4571645B2 JP4571645B2 (ja) | 2010-10-27 |
Family
ID=38156741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006541759A Expired - Fee Related JP4571645B2 (ja) | 2003-12-02 | 2004-12-02 | Ｄ４および５−ｈｔ２ａアンタゴニスト、逆アゴニストまたは部分アゴニストの使用 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4571645B2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1541197T1 (sl) * | 2003-12-02 | 2009-08-31 | Pharmaneuroboost N V | Uporaba pipamperona in sndri, snri ali ssri za zdravljenje razpoloĺ˝enjskih ali tesnobnih motenj |
| EP2248808B1 (en) * | 2008-01-31 | 2014-07-16 | Takeda Pharmaceutical Company Limited | Prophylactic or therapeutic agent for attention deficit/hyperactivity disorder |
| BR112012010670A2 (pt) | 2009-11-06 | 2016-04-12 | Sk Biopharmaceuticals Co Ltd | métodos para tratamento de distúrbio de défict de atenção/hiperatividade |
| JP6466792B2 (ja) * | 2015-07-03 | 2019-02-06 | エスケー バイオファーマスティカルズ カンパニー リミテッド | 注意欠陥／多動性障害（ａｄｈｄ）の治療方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1541197T1 (sl) * | 2003-12-02 | 2009-08-31 | Pharmaneuroboost N V | Uporaba pipamperona in sndri, snri ali ssri za zdravljenje razpoloĺ˝enjskih ali tesnobnih motenj |
-
2004
- 2004-12-02 JP JP2006541759A patent/JP4571645B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023041862A5 (https=) | ||
| JP2021066744A5 (ja) | ブプロピオンおよびデキストロメトルファンを含む組成物 | |
| JP2022180461A5 (https=) | ||
| US20090253728A1 (en) | Methods and Compositions for Treating Nociceptive Pain | |
| JP2005515966A5 (https=) | ||
| JP2013544850A5 (https=) | ||
| JP2005512995A5 (https=) | ||
| HRP20150644T1 (hr) | Metoda za lijeäśenje atrijalne fibrilacije | |
| JP2006504795A5 (https=) | ||
| SK14612003A3 (sk) | Použitie enantiomérne čistého escitalopramu a farmaceutický prostriedok s obsahom escitalopramu | |
| JP2010530422A (ja) | うつ病のための組合せ治療 | |
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| RU2011137131A (ru) | Производные 1-аминоалкилциклогексана для лечения тиннитуса, связанного с потерей слуха или незначительной потерей слуха | |
| JP2007510736A5 (https=) | ||
| RU2010147287A (ru) | Комбинированная композиция | |
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| AR045289A1 (es) | Forma de dosificacion oral de liberacion controlada que comprende 4-(2-di-n-propilaminoetil) - 2(3h)-indolona (ropi-nirol) y uso de dicha forma de dosificacion para la elaboracion de un medicamento | |
| RU2020125170A (ru) | Композиции и способы улучшения биодоступности 5-гидрокситриптофана | |
| RU2007103306A (ru) | Композиции на основе ризедроната и способы их применения | |
| JP2013536837A5 (https=) | ||
| JP2016505050A5 (https=) | ||
| JP2005519936A5 (https=) | ||
| JP2011500589A5 (https=) | ||
| RU2011111792A (ru) | Применение парацетамола и ибупрофена в лечении | |
| RU2007119067A (ru) | Средство для лечения синдрома раздраженного кишечника с преобладанием диареи |